Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
1993-9-28
pubmed:abstractText
We found that 28-mer phosphorothioate oligodeoxynucleotides (S-oligos) with and without sequence specificity complementary to Epstein-Barr virus (EBV) genes are potent inhibitors of EBV replication in cell culture. The decrease in the amount of EBV DNA, the activity of intracellular viral DNA polymerase, and virus production were dose dependent, with a 90% inhibitory dose of approximately 0.5 microM. No inhibition of cell growth was observed with the S-oligos at concentrations up to 20 microM. The mechanism of action appears to be the inhibition of EBV DNA synthesis. The reversibility of anti-EBV action is dependent on the dose and duration of drug exposure. S-oligos should be considered a new class of anti-EBV agents.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8395789-1371582, http://linkedlifedata.com/resource/pubmed/commentcorrection/8395789-14304234, http://linkedlifedata.com/resource/pubmed/commentcorrection/8395789-2163243, http://linkedlifedata.com/resource/pubmed/commentcorrection/8395789-2173699, http://linkedlifedata.com/resource/pubmed/commentcorrection/8395789-2544598, http://linkedlifedata.com/resource/pubmed/commentcorrection/8395789-2830340, http://linkedlifedata.com/resource/pubmed/commentcorrection/8395789-2836790, http://linkedlifedata.com/resource/pubmed/commentcorrection/8395789-2849719, http://linkedlifedata.com/resource/pubmed/commentcorrection/8395789-2992367, http://linkedlifedata.com/resource/pubmed/commentcorrection/8395789-2994045, http://linkedlifedata.com/resource/pubmed/commentcorrection/8395789-2999595, http://linkedlifedata.com/resource/pubmed/commentcorrection/8395789-3000248, http://linkedlifedata.com/resource/pubmed/commentcorrection/8395789-3174622, http://linkedlifedata.com/resource/pubmed/commentcorrection/8395789-3282648, http://linkedlifedata.com/resource/pubmed/commentcorrection/8395789-3499613, http://linkedlifedata.com/resource/pubmed/commentcorrection/8395789-4320657, http://linkedlifedata.com/resource/pubmed/commentcorrection/8395789-4353684, http://linkedlifedata.com/resource/pubmed/commentcorrection/8395789-4872386, http://linkedlifedata.com/resource/pubmed/commentcorrection/8395789-4912237, http://linkedlifedata.com/resource/pubmed/commentcorrection/8395789-6246281, http://linkedlifedata.com/resource/pubmed/commentcorrection/8395789-6302704, http://linkedlifedata.com/resource/pubmed/commentcorrection/8395789-6306771, http://linkedlifedata.com/resource/pubmed/commentcorrection/8395789-6321799, http://linkedlifedata.com/resource/pubmed/commentcorrection/8395789-6641475, http://linkedlifedata.com/resource/pubmed/commentcorrection/8395789-8423768
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0066-4804
pubmed:author
pubmed:issnType
Print
pubmed:volume
37
pubmed:geneSymbol
EBV
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1420-5
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1993
pubmed:articleTitle
Potent inhibition of Epstein-Barr virus by phosphorothioate oligodeoxynucleotides without sequence specification.
pubmed:affiliation
Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06510.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, P.H.S.